Evidence map›Paper›PMID 29850869›Full record

ArticleJournal of neuropathology and experimental neurology2018

Sdha+/- Rats Display Minimal Muscle Pathology Without Significant Behavioral or Biochemical Abnormalities.

Emily M Siebers, Melinda J Choi, Jennifer A Tinklenberg, Margaret J Beatka, Samuel Ayres, Hui Meng, Daniel C Helbling, Akiko Takizawa, Brian Bennett, Alexander M Garces and 5 more

Open access · bronzeAbstract read
In one paragraph

Article in Journal of neuropathology and experimental neurology, 2018. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 9 papers.

0numbers the graph read from it
0cells of the map it votes in
9citing papers in PubMed
0.5field-weighted citation impact, top 37% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

9 citing papers in PubMed, 12 citations in OpenAlex.

  1. Article
  2. Article
  3. A Novel Human SDHA-Knockout Cell Line Model for the Functional Analysis of Clinically Relevant SDHA Variants.Clinical cancer research : an official journal of the American Association for Cancer Research · 2024
    Article
  4. Mitochondrial heterogeneity in diseases.Signal transduction and targeted therapy · 2023
    Review
  5. Article
  6. Article
  7. Article
  8. Article
  9. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

15 authors at 3 institutions in 1 country.

Emily M SiebersDivision of Pediatric Pathology, Department of Pathology and Laboratory Medicine.
Melinda J ChoiDivision of Pediatric Pathology, Department of Pathology and Laboratory Medicine.
Jennifer A TinklenbergDivision of Pediatric Pathology, Department of Pathology and Laboratory Medicine.
Margaret J BeatkaDivision of Pediatric Pathology, Department of Pathology and Laboratory Medicine.
Samuel AyresDivision of Pediatric Pathology, Department of Pathology and Laboratory Medicine.
Hui MengDivision of Pediatric Pathology, Department of Pathology and Laboratory Medicine.
Daniel C HelblingDivision of Pediatric Pathology, Department of Pathology and Laboratory Medicine.
Akiko TakizawaDepartment of Physiology.
Brian BennettDepartment of Physics, Marquette University, Milwaukee, Wisconsin.
Alexander M GarcesDepartment of Physiology.
Luiz-Gabriel Dias Duarte MachadoDepartment of Physics, Marquette University, Milwaukee, Wisconsin.
David DimmockRady Children's Institute for Genomic Medicine, San Diego, California.
Melinda R DwinellDepartment of Physiology.
Aron M GeurtsDepartment of Physics, Marquette University, Milwaukee, Wisconsin.
Michael W LawlorDivision of Pediatric Pathology, Department of Pathology and Laboratory Medicine.
Medical College of Wisconsin · USMarquette University · USChildren’s Institute · US

Funding

Clinical and Translational Science AwardUL1TR001436 · NCATS · MEDICAL COLLEGE OF WISCONSIN · PI FREED, JULIE K · 2015 to 2025
$47.5M
NCATS NIH HHS UL1 TR001436
6 · The paper itself

Abstract

Mitochondrial diseases (MDs) result from alteration of the mitochondrial respiratory chain (MRC) function. Despite the prevalence of MDs in the population, the paucity of animal models available limits the understanding of these disorders. Mutations in SDHA, a gene that codes for the alpha subunit of succinate dehydrogenase (SDH), can cause some forms of MD. SDHA is a crucial contributor to MRC function. In order to expand the range of MD animal models available, we attempted to generate a Sdha knockout rat. Since homozygous Sdha-/- rats could neither be identified in newborn litters, nor as early as embryonic day 14, we evaluated wild-type (WT) and heterozygous Sdha+/- genotypes. No differences in behavioral, biochemical, or molecular evaluations were observed between WT and Sdha+/- rats at 6 weeks or 6 months of age. However, 30% of Sdha+/- rats displayed mild muscle fiber atrophy with rare fibers negative for cytochrome oxidase and SDH on histochemical staining. Collectively, our data provide additional evidence that modeling SDH mutations in rodents may be challenging due to animal viability, and heterozygous rats are insufficiently symptomatic at a phenotypic and molecular level to be of significant use in the study of SDH deficiency.

Indexed as

AnimalsDNA, MitochondrialElectron Transport Complex IIGene Knockout TechniquesHand StrengthMaleMuscle, SkeletalRatsRats, TransgenicDNA, MitochondrialElectron Transport Complex IISDHA protein, human

Identifiers

PMID29850869
PMCPMC6044411
OpenAlexW2805221979

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.